Case Report: Secondary Hemophagocytic Lymphohistiocytosis With Disseminated Infection in Chronic Granulomatous Disease-A Serious Cause of Mortality.
case report
chronic granulomatous disease
hemophagocytic lymphohistiocytosis
infection
inflammation
primary immune deficiency
sepsis
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2020
2020
Historique:
received:
08
07
2020
accepted:
20
10
2020
entrez:
28
12
2020
pubmed:
29
12
2020
medline:
23
6
2021
Statut:
epublish
Résumé
Chronic granulomatous disease (CGD) is a primary immune deficiency due to defects in phagocyte respiratory burst leading to severe and life-threatening infections. Patients with CGD also suffer from disorders of inflammation and immune dysregulation including colitis and granulomatous lung disease, among others. Additionally, patients with CGD may be at increased risk of systemic inflammatory disorders such as hemophagocytic lymphohistiocytosis (HLH). The presentation of HLH often overlaps with symptoms of systemic inflammatory response syndrome (SIRS) or sepsis and therefore can be difficult to identify, especially in patients with a primary immune deficiency in which incidence of infection is increased. Thorough evaluation and empiric treatment for bacterial and fungal infections is necessary as HLH in CGD is almost always secondary to infection. Simultaneous treatment of infection with anti-microbials and inflammation with immunosuppression may be needed to blunt the hyperinflammatory response in secondary HLH. Herein, we present a series of X-linked CGD patients who developed HLH secondary to or with concurrent disseminated CGD-related infection. In two patients, CGD was a known diagnosis prior to development of HLH and in the other two CGD was diagnosed as part of the evaluation for HLH. Concurrent infection and HLH were fatal in three; one case was successfully treated, ultimately receiving hematopoietic stem cell transplantation. The current literature on presentation, diagnosis, and treatment of HLH in CGD is reviewed.
Identifiants
pubmed: 33362767
doi: 10.3389/fimmu.2020.581475
pmc: PMC7756012
doi:
Types de publication
Case Reports
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
581475Subventions
Organisme : NIAID NIH HHS
ID : K23 AI141686
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA154947
Pays : United States
Informations de copyright
Copyright © 2020 Squire, Vazquez, Chan, Smith, Chellapandian, Vose, Teppa, Hanson, Chinn, Forbes-Satter, Seeborg, Nicholas, Martinez, Allen, Connors, Satwani, Shtessel, Ale, Noroski, Rider, Milner and Leiding.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
N Engl J Med. 2020 May 7;382(19):1811-1822
pubmed: 32374962
Crit Rev Oncol Hematol. 2017 Jun;114:1-12
pubmed: 28477737
Blood. 2019 Nov 21;134(21):1783-1786
pubmed: 31537529
Blood Adv. 2019 Jan 8;3(1):47-50
pubmed: 30617216
Blood. 2018 Jul 5;132(1):89-100
pubmed: 29632024
J Pediatric Infect Dis Soc. 2018 May 9;7(suppl_1):S18-S24
pubmed: 29746679
J Pediatr Hematol Oncol. 2014 Apr;36(3):e169-72
pubmed: 23652865
Pediatr Blood Cancer. 2009 Apr;52(4):527-9
pubmed: 19058215
Pediatr Int. 2016 Sep;58(9):817-25
pubmed: 27289085
Curr Opin Hematol. 2017 Jan;24(1):54-58
pubmed: 27755125
Hematol Oncol Clin North Am. 2015 Oct;29(5):927-41
pubmed: 26461152
Pediatr Blood Cancer. 2013 Jan;60(1):101-9
pubmed: 22522603
Pediatr Infect Dis J. 2009 Aug;28(8):753-4
pubmed: 19633526
Pediatr Blood Cancer. 2007 Feb;48(2):124-31
pubmed: 16937360
J Med Microbiol. 2007 May;56(Pt 5):702-705
pubmed: 17446299
J Clin Immunol. 2012 Apr;32(2):207-11
pubmed: 22119934
Pediatr Blood Cancer. 2011 Mar;56(3):460-2
pubmed: 21225928
J Allergy Clin Immunol. 2015 Jun;135(6):1638-41
pubmed: 25592983
Pediatrics. 2014 Dec;134(6):e1727-30
pubmed: 25422023
Clin Immunol. 2014 Oct;154(2):112-5
pubmed: 25063445
Haematologica. 2015 Jul;100(7):978-88
pubmed: 26022711
Pediatr Crit Care Med. 2005 Jan;6(1):2-8
pubmed: 15636651
J Allergy Clin Immunol Pract. 2019 Mar;7(3):824-832
pubmed: 30557712
Drugs. 1999 Feb;57(2):207-13; discussion 214
pubmed: 10188761
Front Immunol. 2019 Feb 01;10:119
pubmed: 30774631
Pediatr Infect Dis J. 2004 Sep;23(9):882-4
pubmed: 15361735
Pediatr Crit Care Med. 2014 Jun;15(5):401-8
pubmed: 24583503